This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Kidney Transplant
and you are
between 18 and 60
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

A prospective, open label study of CERtican in KIdney transplantation

Provided treatments

  • Drug: Everolimus

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01594268. The sponsor of the trial is Novartis Pharmaceuticals and it is looking for 54 volunteers for the current phase.
Official trial title:
A Prospective, Open-label Study to Assess Safety of Certican in Kidney Transplant Patients